Mail

I like iGEM Re: "Brick by brick"1, the iGEM competition is a fantastic idea, and I often hear comments from other scientists saying that they wish there were similar student competitions in other fields of science. The Slovenian team has been singled out not for its achievements but for the alleged hype associated with its project, which I think is not really a fair assessment. The g

Written byThe Scientist
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Re: "Brick by brick"1, the iGEM competition is a fantastic idea, and I often hear comments from other scientists saying that they wish there were similar student competitions in other fields of science. The Slovenian team has been singled out not for its achievements but for the alleged hype associated with its project, which I think is not really a fair assessment. The goal of our project was to prepare a synthetic vaccine against Helicobacter pylori based on several innovative approaches. Within a couple of months, students managed to demonstrate the proof-of-principle for the vaccine. From the proof-of-principle to the working vaccine is a long way, but the potential is there. We are continuing the project and are discussing further development with pharmaceutical companies.

Roman Jerala, Slovenian iGEM team leader
National Institute of Chemistry
Ljubljana, Slovenia
roman.jerala@ki.si

References

Steve Wiley suggests that graduate students benefit first from cold-hard facts, not ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies